Cas:121905-60-0 m-tolylmagnesium chloride manufacturer & supplier

We serve Chemical Name:m-tolylmagnesium chloride CAS:121905-60-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

m-tolylmagnesium chloride

Chemical Name:m-tolylmagnesium chloride
CAS.NO:121905-60-0
Synonyms:MAGNESIUM,CHLORO(3-METHYLPHENYL)-;MFCD00238749;m-methylphenylmagnesium chloride;m-tolylMgCl;3-methylphenylmagnesium chloride;m-Tolylmagnesium chloride solution;m-tolylmagnesium chloride;chlorure de tolyl-3 magnesium
Molecular Formula:C7H7ClMg
Molecular Weight:150.88800
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:110.6ºC at 760 mmHg
Density:0.956 g/mL at 25ºC
Index of Refraction:
PSA:
Exact Mass:150.00900
LogP:2.48470

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3399 4.3/PG 2
Packing Group:


Contact us for information like MAGNESIUM,CHLORO(3-METHYLPHENYL)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,chlorure de tolyl-3 magnesium physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,chlorure de tolyl-3 magnesium Use and application,chlorure de tolyl-3 magnesium technical grade,usp/ep/jp grade.


Related News: One way of leveraging the many benefits of biocatalysis is to partner with an API CDMO offering comprehensive expertise and experience in developing and implementing such technology in GMP commercial production. Diisopropyl-dithiocarbamic acid 3-methyl-benzyl ester manufacturers The green light converts the companies’ accelerated approval to a full approval for endometrial cancer that’s not microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) and for patients whose tumors have progressed following prior treatment. Pyridine, 2,4-dimethyl-6-(3-methyl-5-phenyl-4H-1,2,4-triazol-4-yl)- suppliers Symonds’ board has backed Walmsley’s leadership. In response to Elliott’s open attack earlier this month, the GSK board said it “strongly believes” Walmsley is the “right leader” for the company, citing “widespread and strong support” from GSK’s largest shareholders for Walmsley’s newly unveiled plan to improve the company’s performance. Butanoic acid, 2-azido-4-iodo-, phenylmethyl ester, (S)- vendor & factory.